The NR4A1–NR4A3 cross talk with pro-tumorigenic or tumor-suppressive signaling pathways underwrites a dichotomous and context-dependent role(s) for members of this receptor subfamily (reviewed by Beard et al., 2015, and Wan et al., 2020). The gene discussed is NR4A3; the disease is neoplasm.